$1.$ What are the main differences between the the patented and generic pharmaceutical industries? What are the main differences between the chemical pharmaceutical industry and the biopharmaceutical industry?

$2.$ What activities does a company have to do well in to succeed in the patented biopharmaceutical industry?

$3.$ What conditions IN INDIA represent advantages or disadvantages for Indian companies in competing in the patented biopharmaceutical industry?

Please use BOTH the ARC framework AND Porter's "Diamond" model to make your assessments

$4.$ What do you conclude are India's prospects for succeeding in the patented biopharmaceutical industry? Please explain your reasoning.

Note that answers to these questions should focus on INDIA rather than BIOCON.